Metabolomics Market 2021-2030

PORTLAND, OREGON, UNITED STATES, June 3, 2024 /EINPresswire.com/ -- The global metabolomics market size was valued at $2,032 Million in 2020, and is projected to reach $6,663 Million by 2030, registering a CAGR of 12.2% from 2021 to 2030.

Growth in R&D expenditure in the pharmaceutical & biopharmaceutical industry, availability of government & private funding for metabolomics research, and ongoing innovations in metabolomics instruments drive the growth of the global metabolomics industry.

Key Takeaways:

Personalized medicine is expected to continue this trend during the forecast period.
Neurological disorder market is anticipated to grow at the highest CAGR during the forecast period.
Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

For Right Perspective, Request Sample Copy of the Report: https://www.alliedmarketresearch.com/request-sample/525

The fact that metabolomics has the ability to detect a large number of metabolites from fluid or tissue sample in a single step and it can also yield great amounts leads to a steep rise in demand for metabolomics, thereby driving the growth of the market. On the other hand, high cost of metabolomics instruments and scarcity of professionals restrain the growth to some extent. However, technological advancements in analytical techniques and upsurge in R&D expenditure are expected to create an array of opportunities in the industry.

Major Factors Driving the Growth of Metabolomics Market:

High-throughput Techniques: The development of high-throughput technologies such as mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy has greatly enhanced the ability to analyze metabolites with high precision and accuracy.

Bioinformatics and Data Analysis Tools: Improved bioinformatics tools and software for data analysis have made it easier to interpret complex metabolomic data, facilitating more efficient and insightful research.

Pharmaceutical and Biotechnology Industries: There is a growing focus on R&D activities within pharmaceutical and biotechnology companies to discover new biomarkers for disease diagnosis, drug development, and personalized medicine.

Academic and Research Institutions: Increased funding and support for academic research projects have also fueled advancements in metabolomics studies.

Connect to our Analyst: https://www.alliedmarketresearch.com/request-for-customization/525

Metabolomics Market Segments:

By PRODUCT AND SERVICES

Metabolomics Instruments
Metabolomics Bioinformatics Tools And Services

By APPLICATION

Biomarker Discovery
Drug Discovery
Toxicology Testing
Nutrigenomics
Functional Genomics
Personalized Medicine
Other Applications

By INDICATION

Cancer
Cardiovascular Disorders
Neurological Disorders
Inborn Errors Of Metabolism
Other Indications

By Region

North America (U.S., Canada, Mexico)
Europe (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
Asia-Pacific (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
LAMEA (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)

Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/525

On the basis of region, North America contributed to the major market share in terms of revenue 2020, holding more than two-fifths of the global metabolomics market, owing to surge in research activities which involve the use of metabolomics. Asia-Pacific, on the other hand, is projected to cite the fastest CAGR of 13.9% from 2021 to 2030. This is due to rise in awareness related to use of metabolomics.

Prominent market players:

Bio-Rad Laboratories INC.
Agilent Technologies INC.
Bruker corporation
Danaher Corporation
Human Metabolome Technologies INC.
LECO Corporation
Metabolon INC.
BiocratesLife Science AG
Water Corporation
Shimadzu Corporation

CUSTOMIZATION OPTIONS:

Distributor Landscape Assessment
Pricing Intelligence
Customer Base Assessment
Investment & Initiatives Analysis
‘Business Profile’ of Key Players
About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Market Research
+ 18007925285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.